Additionally, CGRP may trigger the release of pro-inflammatory cytokines (Ray et al., 2021), particularly IL-6 and TNF-α, which are also increased in the plasm of migraine patients (Yücel et al., 2016; Conti et al., 2019). The gene discussed is IL6; the disease is migraine disorder.